Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs062200061Recruiting
Open-label, single-arm trial of docetaxel in prostate cancer (PCa). Primary endpoint: peripheral neuropathy. Started Apr 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs062200061.